
Kerry Group plc
Kerry
Kerry Group is a global leader in taste, nutrition, and pharmaceutical excipients, headquartered in Tralee, County Kerry, Ireland. Founded in 1972 and listed on the Euronext Dublin (ISEQ: KRZ) and London Stock Exchange (LSE: KYGA), Kerry generates over €8 billion in annual revenue with 21,000+ employees across 150+ manufacturing sites worldwide. Its Sheffield Bio-Science division is a critical supplier of cell culture media supplements and high-purity pharmaceutical lactose for the global biopharmaceutical industry.
Strengths: Sheffield Bio-Science — proprietary fermentation technology for animal-origin-free cell culture supplements; global manufacturing footprint with 150+ facilities providing multi-region supply redundancy; deep pharmaceutical excipient portfolio including high-specification lactose for dry powder inhalers and direct compression formulations; vertically integrated dairy supply chain ensuring raw material security and traceability; R&D investment of €300M+ annually across global innovation centers.
Weaknesses: revenue dominated by food ingredients — pharma excipients represent a minority of group sales, limiting strategic focus; manufacturing concentration in Europe with fewer pharma-dedicated facilities in North America and Asia; limited presence in lipid nanoparticles and advanced drug delivery systems compared to Croda and Evonik.Read More ▼Show Less ▲
Strengths: Sheffield Bio-Science — proprietary fermentation technology for animal-origin-free cell culture supplements; global manufacturing footprint with 150+ facilities providing multi-region supply redundancy; deep pharmaceutical excipient portfolio including high-specification lactose for dry powder inhalers and direct compression formulations; vertically integrated dairy supply chain ensuring raw material security and traceability; R&D investment of €300M+ annually across global innovation centers.
Weaknesses: revenue dominated by food ingredients — pharma excipients represent a minority of group sales, limiting strategic focus; manufacturing concentration in Europe with fewer pharma-dedicated facilities in North America and Asia; limited presence in lipid nanoparticles and advanced drug delivery systems compared to Croda and Evonik.
Business Nature
Manufacturing: 100% self-production with owned facilities worldwide. Headquarters in Tralee, Ireland with unified global operations.
Business Model: B2B-focused, serving global food manufacturers and foodservice chains. Operations in 150+ countries.
Listed: Dublin ESM: KRZ / London LSE: KYGA Stock Exchanges
Core Business Areas
Industry Rankings
Corporate Report
VerityRank Score
Based on market presence, financial scale, operational capacity, and brand strength.
Quick Facts
Headquarters
Tralee, County Kerry, Ireland
Founded
1972
Employees
23K+
Factories
150+
Listing
Publicly Listed
Categories
Data Sources & Methodology
This corporate profile is compiled from publicly available sources including company annual reports, SEC/regulatory filings, official press releases, and verified third-party industry databases. Financial figures reflect the most recent fiscal year disclosures and are cross-validated across multiple independent references.
VerityRank Score is calculated using a proprietary multi-dimensional model evaluating market presence, financial strength, operational scale, innovation capacity, and brand influence. Individual dimension scores are normalized against industry peers and updated quarterly.
Disclaimer: This profile is for informational purposes only. VerityRank makes no warranties regarding completeness or timeliness. This content does not constitute investment advice or endorsement.
Key references: Euronext Dublin : KRZ , Kerry Group Official Website
Grand View Research — Excipients Market Analysis
Mordor Intelligence — API Market
